Kennedy Jr. has his way, get ready for even more anti-pharma rhetoric and potential instability at ... FDA and has called for ...

To hear GSK CEO Emma Walmsley tell it, the third quarter presented “some challenges” for the drugmaker. | To hear GSK CEO ...

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...

From the GlaxoSmithKline bribery scandal in China to Merck's product liability lawsuit to ... Ed Silverman provides his views on the latest pharmaceutical news from the last four weeks.

GSK shares were down 3.9%, as of 0958 GMT, after earlier hitting their lowest since November 2023. Maggie is a Britain-based reporter covering the European pharmaceuticals industry with a global ...

British pharmaceutical company GSK said on Wednesday that it has agreed ... of the Zantac state court product liability cases pending against GSK," the company said in a statement.

Bearish flow noted in GSK (GSK) Pharma with 3,674 puts trading, or 5x expected. Most active are 10/25 weekly 38 puts and Nov-24 40 calls, with total volume in those strikes near 3,100 contracts.

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

British pharmaceutical company GSK on Wednesday said it swung into a ... to offset lower vaccine sales and reflected successful new product launches in oncology and HIV," chief executive Emma ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary ... Also, they introduced the Animal health products. In the year 1971, the company built the Research & development laboratory at Thane.

Pharmaceutical and agricultural companies are among the industry groups pushing against a proposed levy on their returns from ...